EMA recommends revoking marketing authorisation for Amgen's rare disease drug
أمجين
Amgen Inc. AMGN | 0.00 |
June 26 (Reuters) - The European Medicines Agency on Friday recommended revoking the marketing authorisation for Amgen's AMGN.O rare disease drug Tavneos.